# Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study

> **NCT01505959** · PHASE4 · UNKNOWN · sponsor: **Fédération Française de Pneumologie** · enrollment: 936 (estimated)

## Conditions studied

- Sleep Apnea Syndromes
- High Cardiovascular Risk

## Interventions

- **DEVICE:** CPAP treatment
- **DEVICE:** CPAP treatment

## Key facts

- **NCT ID:** NCT01505959
- **Lead sponsor:** Fédération Française de Pneumologie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 936 (ESTIMATED)
- **Last updated:** 2014-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505959, "Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01505959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*